COUR - NIVF BDRX and ZAPP among pre-market losers
2024-04-30 08:24:49 ET
More on pre-market losers & stocks.
- Biodexa shares rally 126% on rapamycin licensing deal
- NewGenIvf signs non-binding term sheet for potential reverse merger with European Wellness Investment Holdings
- Seeking Alpha’s Quant Rating on Biodexa Pharmaceuticals
- Historical earnings data for Biodexa Pharmaceuticals
- Financial information for Biodexa Pharmaceuticals